trial · primary record
Dara-RVd
Multiple Myeloma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 65 |
| Primary completion | 2029-07-24 |
| Primary endpoint | Phase I: Toxicity |
| Registry ID | NCT07099391 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:37.619Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07099391
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.